Capricorn Venture Partners expands its senior team and launches Capricorn Health-tech Fund

Leuven, Belgium: 21 October 2009 - Capricorn Venture Partners is pleased to announce the launch of its Capricorn Health-tech Fund (CHF).

The objective is to raise € 100 to € 120 million venture capital for a new fund focusing on early to mid stage human health-technology investments in Europe.

Capricorn Venture Partners defines health-technology investments as investments in companies whose business and products relate to the prevention, the diagnosis or the treatment of diseases. The human health-technology sector comprises a diverse range of products and services including biopharmaceutical and pharmaceutical drugs, vaccines, medical devices, medical imaging, diagnostics, nutraceuticals and functional foods.

More info on the press release.